Carlos Fernandez-Teruel
5PUBLICATIONS
12CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (5)
Sort by Publication Date:
|Jul 08, 2025
Population Pharmacokinetics and Exposure-Response Analyses for Capivasertib in Combination With Fulvestrant in Patients With Breast Cancer.Carlos Fernandez Teruel, Marie Cullberg, Ignacio González-García
|Aug 10, 2024
Population Pharmacokinetics of Capivasertib in Patients with Advanced or Metastatic Solid Tumours.Carlos Fernandez-Teruel, Marie Cullberg, Cath Eberlein
|Nov 05, 2021
Integrated exposure-response analysis of efficacy and safety of lurbinectedin to support the dose regimen in small-cell lung cancer.Carlos Fernández-Teruel, Salvador Fudio, Rubin Lubomirov
|Oct 27, 2020
Effect of lurbinectedin on the QTc interval in patients with advanced solid tumors: an exposure-response analysis.Salvador Fudio, Josep Tabernero, Vivek Subbiah
|Aug 10, 2018
Population-Pharmacokinetic and Covariate Analysis of Lurbinectedin (PM01183), a New RNA Polymerase II Inhibitor, in Pooled Phase I/II Trials in Patients with Cancer.Carlos Fernandez-Teruel, Ignacio Gonzalez, Iñaki F Trocóniz
Pageof 1
Frequent Collaborators
3 joint publications
Rubin Lubomirov
3 joint publications
Salvador Fudio
2 joint publications
Marie Cullberg
2 joint publications
Ignacio González-García
2 joint publications
Diansong Zhou
1 joint publications
Gaia Schiavon
1 joint publications
Ling Zhang
1 joint publications
Iñaki F Trocóniz
1 joint publications
Arturo Soto
1 joint publications
Vicente Alfaro
